Nivolumab shows promise in advanced cutaneous squamous cell carcinoma
Findings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...
top of page
it's where dermatology lives
Featured Posts
bottom of page